609 related articles for article (PubMed ID: 20490627)
21. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force.
Davis SP; Landis BJ; Adams ZH; Allen MG; Prausnitz MR
J Biomech; 2004 Aug; 37(8):1155-63. PubMed ID: 15212920
[TBL] [Abstract][Full Text] [Related]
22. Enhanced skin delivery of vismodegib by microneedle treatment.
Nguyen HX; Banga AK
Drug Deliv Transl Res; 2015 Aug; 5(4):407-23. PubMed ID: 26069156
[TBL] [Abstract][Full Text] [Related]
23. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
[TBL] [Abstract][Full Text] [Related]
24. Coating formulations for microneedles.
Gill HS; Prausnitz MR
Pharm Res; 2007 Jul; 24(7):1369-80. PubMed ID: 17385011
[TBL] [Abstract][Full Text] [Related]
25. A key role by polymers in microneedle technology: a new era.
Rajput A; Kulkarni M; Deshmukh P; Pingale P; Garkal A; Gandhi S; Butani S
Drug Dev Ind Pharm; 2021 Nov; 47(11):1713-1732. PubMed ID: 35332822
[TBL] [Abstract][Full Text] [Related]
26. Levothyroxine sodium loaded dissolving microneedle arrays for transdermal delivery.
Ghazi RF; Al-Mayahy MH
ADMET DMPK; 2022; 10(3):213-230. PubMed ID: 36131889
[TBL] [Abstract][Full Text] [Related]
27. Microneedles for transdermal drug delivery: a minireview.
Vandervoort J; Ludwig A
Front Biosci; 2008 Jan; 13():1711-5. PubMed ID: 17981662
[TBL] [Abstract][Full Text] [Related]
28. Effect of microneedle geometry and supporting substrate on microneedle array penetration into skin.
Kochhar JS; Quek TC; Soon WJ; Choi J; Zou S; Kang L
J Pharm Sci; 2013 Nov; 102(11):4100-8. PubMed ID: 24027112
[TBL] [Abstract][Full Text] [Related]
29. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration.
Sivamani RK; Stoeber B; Wu GC; Zhai H; Liepmann D; Maibach H
Skin Res Technol; 2005 May; 11(2):152-6. PubMed ID: 15807814
[TBL] [Abstract][Full Text] [Related]
30. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery.
Yan G; Warner KS; Zhang J; Sharma S; Gale BK
Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808
[TBL] [Abstract][Full Text] [Related]
31. The Use of a Pressure-Indicating Sensor Film to Provide Feedback upon Hydrogel-Forming Microneedle Array Self-Application In Vivo.
Vicente-Pérez EM; Quinn HL; McAlister E; O'Neill S; Hanna LA; Barry JG; Donnelly RF
Pharm Res; 2016 Dec; 33(12):3072-3080. PubMed ID: 27633885
[TBL] [Abstract][Full Text] [Related]
32. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.
Al-Qallaf B; Das DB
J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071
[TBL] [Abstract][Full Text] [Related]
33. Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety.
Donnelly RF; Singh TR; Alkilani AZ; McCrudden MT; O'Neill S; O'Mahony C; Armstrong K; McLoone N; Kole P; Woolfson AD
Int J Pharm; 2013 Jul; 451(1-2):76-91. PubMed ID: 23644043
[TBL] [Abstract][Full Text] [Related]
34. Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery.
Park JH; Yoon YK; Choi SO; Prausnitz MR; Allen MG
IEEE Trans Biomed Eng; 2007 May; 54(5):903-13. PubMed ID: 17518288
[TBL] [Abstract][Full Text] [Related]
35. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin.
Kim M; Jung B; Park JH
Biomaterials; 2012 Jan; 33(2):668-78. PubMed ID: 22000788
[TBL] [Abstract][Full Text] [Related]
36. Delivery of Methotrexate and Characterization of Skin Treated by Fabricated PLGA Microneedles and Fractional Ablative Laser.
Nguyen HX; Banga AK
Pharm Res; 2018 Feb; 35(3):68. PubMed ID: 29468316
[TBL] [Abstract][Full Text] [Related]
37. Microneedles and transdermal applications.
Sivamani RK; Liepmann D; Maibach HI
Expert Opin Drug Deliv; 2007 Jan; 4(1):19-25. PubMed ID: 17184159
[TBL] [Abstract][Full Text] [Related]
38. Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium.
Gomaa YA; Garland MJ; McInnes F; El-Khordagui LK; Wilson C; Donnelly RF
Eur J Pharm Biopharm; 2012 Oct; 82(2):299-307. PubMed ID: 22836025
[TBL] [Abstract][Full Text] [Related]
39. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
[TBL] [Abstract][Full Text] [Related]
40. An update on coating/manufacturing techniques of microneedles.
Tarbox TN; Watts AB; Cui Z; Williams RO
Drug Deliv Transl Res; 2018 Dec; 8(6):1828-1843. PubMed ID: 29288358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]